353 related articles for article (PubMed ID: 27254481)
1. Association of Socioeconomic Status and Race/Ethnicity With Treatment and Survival in Patients With Medullary Thyroid Cancer.
Roche AM; Fedewa SA; Chen AY
JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):763-71. PubMed ID: 27254481
[TBL] [Abstract][Full Text] [Related]
2. Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer.
Roche AM; Fedewa SA; Shi LL; Chen AY
Cancer; 2018 Apr; 124(8):1780-1790. PubMed ID: 29409119
[TBL] [Abstract][Full Text] [Related]
3. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
4. Disparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population.
Corey L; Cote ML; Ruterbusch JJ; Vezina A; Winer I
Am J Obstet Gynecol; 2022 Apr; 226(4):541.e1-541.e13. PubMed ID: 34736911
[TBL] [Abstract][Full Text] [Related]
5. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery.
Morgan JW; Ji L; Friedman G; Senthil M; Dyke C; Lum SS
JAMA Surg; 2015 Jan; 150(1):37-43. PubMed ID: 25426671
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
Leggett MD; Chen SL; Schneider PD; Martinez SR
Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930
[TBL] [Abstract][Full Text] [Related]
7. Does socioeconomic status account for racial and ethnic disparities in childhood cancer survival?
Kehm RD; Spector LG; Poynter JN; Vock DM; Altekruse SF; Osypuk TL
Cancer; 2018 Oct; 124(20):4090-4097. PubMed ID: 30125340
[TBL] [Abstract][Full Text] [Related]
8. Effect of radiation therapy on survival in patients with resected Merkel cell carcinoma: a propensity score surveillance, epidemiology, and end results database analysis.
Kim JA; Choi AH
JAMA Dermatol; 2013 Jul; 149(7):831-8. PubMed ID: 23864085
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma.
Kuo EJ; Sho S; Li N; Zanocco KA; Yeh MW; Livhits MJ
JAMA Surg; 2018 Jan; 153(1):52-59. PubMed ID: 28973144
[TBL] [Abstract][Full Text] [Related]
10. External Beam Radiotherapy for Medullary Thyroid Cancer Following Total or Near-Total Thyroidectomy.
Jin M; Megwalu UC; Noel JE
Otolaryngol Head Neck Surg; 2021 Jan; 164(1):97-103. PubMed ID: 32746731
[TBL] [Abstract][Full Text] [Related]
11. [Postoperative external beam radiotherapy for medullary thyroid carcinoma with high risk of locoregional relapse].
Compagnon F; Zerdoud S; Rives M; Laprie A; Sarini J; Grunenwald S; Chaltiel L; Graff P
Cancer Radiother; 2016 Jul; 20(5):362-9. PubMed ID: 27396902
[TBL] [Abstract][Full Text] [Related]
12. Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis.
Qu N; Shi RL; Lu ZW; Liao T; Wen D; Sun GH; Li DS; Ji QH
Oncotarget; 2016 Oct; 7(40):65937-65945. PubMed ID: 27588396
[TBL] [Abstract][Full Text] [Related]
13. Racial disparities in cancer-related survival in patients with squamous cell carcinoma of the esophagus in the US between 1973 and 2013.
Kim A; Ashman P; Ward-Peterson M; Lozano JM; Barengo NC
PLoS One; 2017; 12(8):e0183782. PubMed ID: 28832659
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study.
Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G
Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance and optimal cutoff of age in medullary thyroid cancer.
Qu N; Shi RL; Luo TX; Wang YL; Li DS; Wang Y; Huang CP; Ji QH
Oncotarget; 2016 Mar; 7(13):15937-47. PubMed ID: 26910117
[TBL] [Abstract][Full Text] [Related]
16. Rethinking the Current American Joint Committee on Cancer TNM Staging System for Medullary Thyroid Cancer.
Adam MA; Thomas S; Roman SA; Hyslop T; Sosa JA
JAMA Surg; 2017 Sep; 152(9):869-876. PubMed ID: 28636692
[TBL] [Abstract][Full Text] [Related]
17. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.
Tannenbaum SL; Koru-Sengul T; Zhao W; Miao F; Byrne MM
Cancer J; 2014; 20(4):237-45. PubMed ID: 25098282
[TBL] [Abstract][Full Text] [Related]
18. Racial Disparities in Differentiated Thyroid Cancer: Have We Bridged the Gap?
Shah SA; Adam MA; Thomas SM; Scheri RP; Stang MT; Sosa JA; Roman SA
Thyroid; 2017 Jun; 27(6):762-772. PubMed ID: 28294040
[TBL] [Abstract][Full Text] [Related]
19. Impact of extensive neck dissection on survival from papillary thyroid cancer.
Kandil E; Friedlander P; Noureldine S; Islam T; Tufano RP
ORL J Otorhinolaryngol Relat Spec; 2011; 73(6):330-5. PubMed ID: 21997375
[TBL] [Abstract][Full Text] [Related]
20. Associations Between Race/Ethnicity and US Childhood and Adolescent Cancer Survival by Treatment Amenability.
Delavar A; Barnes JM; Wang X; Johnson KJ
JAMA Pediatr; 2020 May; 174(5):428-436. PubMed ID: 32091555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
